At close: December 20 at 4:00:02 PM EST
After hours: December 20 at 5:18:52 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -0.41 | -0.41 | -1.79 | -1.38 |
| Low Estimate | -0.41 | -0.41 | -1.79 | -1.38 |
| High Estimate | -0.41 | -0.41 | -1.79 | -1.38 |
| Year Ago EPS | -0.47 | -0.45 | -1.83 | -1.79 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 1 | 2 | 2 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.54 | -0.57 | -0.55 | -0.47 |
| EPS Actual | -0.47 | -0.45 | -0.47 | -0.32 |
| Difference | 0.07 | 0.12 | 0.08 | 0.15 |
| Surprise % | 12.96% | 21.05% | 14.55% | 31.91% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.41 | -0.41 | -1.79 | -1.38 |
| 7 Days Ago | -0.42 | -0.42 | -1.86 | -1.37 |
| 30 Days Ago | -0.42 | -0.42 | -1.86 | -1.39 |
| 60 Days Ago | -0.42 | -0.42 | -1.86 | -1.39 |
| 90 Days Ago | -0.42 | -0.42 | -1.86 | -1.39 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 1 | -- | 1 |
| Up Last 30 Days | -- | 1 | -- | 1 |
| Down Last 7 Days | 1 | -- | 1 | -- |
| Down Last 30 Days | 1 | -- | 1 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| INDP | 12.77% | 8.89% | 2.19% | 22.91% |
| S&P 500 | 5.00% | 12.00% | 2.10% | 12.20% |
Upgrades & Downgrades
| Maintains | Maxim Group: Buy to Buy | 11/13/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 10/16/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 6/17/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/15/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 9/20/2023 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/15/2023 |
Related Tickers
ZIVO ZIVO Bioscience, Inc.
18.00
+2.27%
AKTX Akari Therapeutics, Plc
0.9700
-3.00%
KTTA Pasithea Therapeutics Corp.
2.6300
-1.50%
COEP Coeptis Therapeutics Holdings, Inc.
0.1415
-2.08%
ANRO Alto Neuroscience, Inc.
3.8900
+4.57%
EDSA Edesa Biotech, Inc.
1.7300
-1.14%
BCDA BioCardia, Inc.
1.9700
+7.07%
ACTU Actuate Therapeutics, Inc. Common stock
6.77
-3.97%
IPA ImmunoPrecise Antibodies Ltd.
0.4001
-4.74%
AZTR Azitra, Inc.
0.4150
+5.01%